An Open-label, Multi-center, Single-dose, Parallel-group Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
Latest Information Update: 07 Dec 2023
At a glance
- Drugs Tegoprazan (Primary)
- Indications Erosive oesophagitis; Gastric cancer; Gastro-oesophageal reflux; Helicobacter infections
- Focus Pharmacokinetics
- Sponsors HK inno.N
- 05 Nov 2020 Status changed from not yet recruiting to recruiting.
- 04 Aug 2020 New trial record